Effects of raloxifene on normal breast tissue from premenopausal women Benedito Borges da SilvaIone Maria Ribeiro Soares LopesLuiz Henrique Gebrim OriginalPaper 13 December 2005 Pages: 99 - 103
Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland Jacek GronwaldTomasz ByrskiJan Lubinski Preclinical study 27 October 2005 Pages: 105 - 109
Accuracy and reliability of sentinel node biopsy in patients with breast cancer. Single centre study with long term follow-up P. CarcoforoD. SortiniA. Liboni Clinical trial 22 October 2005 Pages: 111 - 116
Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients Madeleine M.A. Tilanus-LinthorstKarina C.M. BartelsCecile T.M. Brekelmans OriginalPaper 01 December 2005 Pages: 117 - 123
The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy Val ShillingValerie JenkinsIvonne Solis Trapala Clinical trial 27 October 2005 Pages: 125 - 129
Antidepressant use and breast cancer risk Chloe ChienChristopher I. LiJanet R. Daling Report 02 December 2005 Pages: 131 - 140
Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer Marcin Radosław LenerDorota OszutowskaJan Lubiński Epidemiology 03 November 2005 Pages: 141 - 145
Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case–control analysis Eva Ruvalcaba-LimónCarlos Robles-VidalDiana Vilar-Compte OriginalPaper 01 December 2005 Pages: 147 - 152
Microsatellite profile in hormonal receptor genes associated with breast cancer C. IobagiuC. LambertC. Genin OriginalPaper 30 November 2005 Pages: 153 - 159
Promoter methylation reduces C/EBPδ (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors D. TangG.S. SivkoJ.W. DeWille OriginalPaper 02 December 2005 Pages: 161 - 170
Pre-diagnosis physical activity and mammographic density in breast cancer survivors Melinda L. IrwinErin J. AielloRachel Ballard-Barbash OriginalPaper 30 November 2005 Pages: 171 - 178
Different clinical impact of estradiol receptor determination according to the analytical method: a study on 1940 breast cancer patients over a period of 16 consecutive years N. MagnéR.-A. ToillonM. Namer OriginalPaper 30 November 2005 Pages: 179 - 184
Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression Mary GrilloMatthew J. BottSridhar K. Rabindran Report 01 December 2005 Pages: 185 - 194